The BSE Sensex declined 364.62 points to 81,883.99 and the NSE Nifty 50 fell 117.15 points to 25,379.40 in early trading on Friday. According to reports from Livemint, the benchmark indices were influenced by sluggish global market trends and new outflows from foreign funds. Notable decliners included Maruti, Bharti Airtel, Hindustan Unilever, Mahindra & Mahindra, Kotak Mahindra Bank, and UltraTech Cement. In contrast, Infosys, Tech Mahindra, HCL Tech, and Eternal saw gains during the session.
Foreign Institutional Investors (FIIs) sold equities worth ₹3,465.99 crore on Thursday, as per exchange statistics reported by Livemint. However, Domestic Institutional Investors (DIIs) purchased stocks valued at ₹5,031.57 crore, indicating strong domestic support for the market. This divergence in institutional flows highlights the contrasting sentiment between foreign and domestic investors in the current market environment.
According to Axis Securities analysis reported by Livemint, Samvardhana Motherson International Ltd is trading at ₹135 and remains in a strong uptrend across all time frames. The stock has been consolidating within a minor falling channel since February 11th, 2026, with a recent decisive breakout signaling continuation of the primary uptrend. Investors are advised to consider buying, holding, and accumulating this stock with an expected upside of 145-155 levels and downside support at 132-128 levels.
As reported by Axis Securities to Livemint, Indusind Bank Ltd is trading at ₹965 and is trending within a well-defined rising channel with consistent higher highs and higher lows. The stock delivered a decisive breakout above the multiple resistance zone around ₹958, supported by healthy volumes reflecting strong bullish participation. Investors are recommended to consider buying, holding, and accumulating this stock with an expected upside of ₹1000-1020 levels and downside support at ₹940-920 levels.
According to Axis Securities analysis reported by The Hindu BusinessLine, Fortis Healthcare Ltd is trading at ₹932.85 and has confirmed a decisive breakout above the inverted head and shoulders pattern at ₹949 on a closing basis. The stock remains firmly positioned above its 20, 50, 100, and 200-day SMAs with all key averages trending higher. Fortis delivered strong performance in 9M-FY26 with consolidated revenue of ₹6,763 crore and EBITDA margins at 22.9%, registering robust 17.1% growth primarily driven by the hospital segment's 19.1% growth. The company's diagnostics business rebranded to Agilus Diagnostics reported revenue growth of 7.7% to ₹1,139 crore with operating EBITDA increasing to ₹275 crore from ₹185 crore, resulting in margin expansion to 24.1%.
